CDC Travel Health Advisories and Traveler Guidance
The Centers for Disease Control and Prevention issues structured travel health guidance that helps clinicians, travelers, and public health officials assess destination-specific disease risks and countermeasures. This page covers how advisory levels are defined, the mechanism by which they are updated, the scenarios under which different advisory tiers apply, and the decision logic that governs when travelers and providers should act on each level. The CDC's travel health program represents one of the most operationally visible parts of the agency's broader public health mandate, directly affecting millions of international departures from the United States each year.
Definition and Scope
CDC Travel Health Notices are formal, tiered risk communications issued by CDC's Division of Global Migration and Quarantine (DGMQ) and the Travelers' Health Branch. They are distinct from the U.S. Department of State's travel advisories, which address security and political risk. CDC notices address infectious disease and public health risk specifically.
The scope of the program encompasses pre-travel vaccine recommendations, destination-specific disease profiles, outbreak alerts, and guidance for special populations including pregnant travelers, immunocompromised individuals, and travelers visiting friends and relatives (VFR travelers) — a group that CDC research identifies as carrying disproportionately elevated risk due to longer stays, more intimate contact with local populations, and lower rates of pre-travel consultation.
CDC travel health notices are published on the CDC Travelers' Health website and are updated in response to epidemiological intelligence gathered through CDC disease surveillance systems, WHO situation reports, and in-country partner data.
How It Works
CDC issues Travel Health Notices on a 3-level scale that directly mirrors risk magnitude:
- Level 1 – Practice Usual Precautions: The destination poses no atypical infectious disease risk above baseline. Standard pre-travel consultation, routine vaccinations, and basic hygiene apply.
- Level 2 – Practice Enhanced Precautions: An elevated risk exists — typically an ongoing outbreak, seasonal disease surge, or confirmed transmission of a pathogen requiring specific prophylaxis or behavioral modification. Travelers may need destination-specific vaccines or antimalarials beyond routine schedules.
- Level 3 – Avoid Nonessential Travel: A serious or rapidly evolving public health threat is present. This level is reserved for situations where standard precautions cannot adequately reduce risk, or where healthcare infrastructure at the destination is insufficient to manage illness in travelers.
The tiering decision draws on criteria including: attack rate among susceptible populations, availability of effective prophylaxis or post-exposure treatment, healthcare capacity at the destination, and speed of outbreak escalation. DGMQ epidemiologists coordinate with the CDC Global Health Operations team and the World Health Organization's International Health Regulations (IHR) focal point network to validate ground-level data before issuing or upgrading a notice.
Separate from the tiered notice system, CDC maintains destination pages on the Travelers' Health site covering required vaccinations (those mandated by a destination country's entry rules), recommended vaccinations (driven by epidemiological risk), and routine vaccines that should be current regardless of destination. Yellow fever vaccine, for example, is required by 40+ countries and regulated under IHR Annex 7 as a condition of entry.
Common Scenarios
Outbreak Response Activation: When a novel or resurging pathogen reaches threshold case counts in a destination country — as occurred during the 2022 mpox outbreak, which prompted CDC to issue a Level 2 notice — DGMQ escalates the relevant destination notice and publishes a clinical guidance document for U.S. healthcare providers seeing returned travelers.
Seasonal Disease Surges: Destinations with predictable transmission seasons for malaria, dengue, or chikungunya may have standing Level 1 or Level 2 notices that are reviewed and updated on a defined cycle. Travelers to sub-Saharan Africa, for instance, face year-round malaria risk in most regions, and CDC's destination pages specify whether Plasmodium falciparum or P. vivax predominates — a clinically significant distinction because chloroquine-resistant P. falciparum requires atovaquone-proguanil, doxycycline, or mefloquine prophylaxis.
Cruise and Maritime Travel: CDC's Vessel Sanitation Program (VSP) operates alongside the travel notice system. Cruise-specific disease alerts — particularly for norovirus outbreaks — are issued separately from destination notices, as the transmission environment aboard a vessel differs from land-based travel.
Mass Gatherings: Events such as the Hajj pilgrimage in Saudi Arabia generate standing CDC guidance that covers meningococcal vaccine requirements (Saudi Arabia mandates quadrivalent MenACWY for Hajj visas), respiratory illness risk, and heat-related illness, illustrating that a single destination may carry multiple concurrent health risks at a given time of year.
Decision Boundaries
The 3-level notice framework creates practical decision points for two distinct audiences: travel medicine providers and travelers themselves.
For travel medicine clinicians, a Level 2 notice triggers a structured pre-travel consultation that goes beyond vaccine administration. Providers assess traveler-specific factors — immunocompromise, pregnancy, cardiovascular disease — against the destination risk profile documented in the notice. CDC's Yellow Book (Health Information for International Travel), published biannually, is the primary clinical reference that providers use to map notice-level risk to individualized prophylaxis decisions.
For travelers, Level 3 notices carry the strongest behavioral signal short of an outright entry prohibition (which is a State Department function, not CDC's). CDC explicitly frames Level 3 as "avoid nonessential travel" rather than a mandate, because the agency lacks the legal authority to prohibit civilian travel — a boundary defined within CDC's quarantine and legal authority framework.
Notice level vs. country-specific entry requirement: These are frequently confused. A destination country may require proof of yellow fever vaccination regardless of CDC's notice level for that country. Conversely, CDC may issue a Level 2 notice for a destination that imposes no special entry health requirements. Travelers and clinicians must consult both the CDC destination page and the destination country's official entry rules independently.
Pregnant traveler boundary: CDC guidance draws a hard line on certain destinations for pregnant travelers independent of notice level. Zika virus transmission zones, for example, carry a standing recommendation against nonessential travel for pregnant individuals regardless of the current active notice tier — because the teratogenic risk of Zika infection during pregnancy operates on a different threshold than outbreak-response logic.